4//SEC Filing
Sands Capital Ventures Discovery Fund III, L.P. 4
Accession 0000899243-21-027891
CIK 0001576885other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 5:21 PM ET
Size
19.7 KB
Accession
0000899243-21-027891
Insider Transaction Report
Form 4
Transactions
- Conversion
Common Stock
2021-07-06+1,124,729→ 1,124,729 total - Conversion
Series A-1 Preferred Stock
2021-07-06−1,124,729→ 0 total→ Common Stock (1,124,729 underlying) - Conversion
Series B Preferred Stock
2021-07-06−1,842,346→ 0 total→ Common Stock (1,842,346 underlying) - Conversion
Common Stock
2021-07-06+1,842,346→ 2,967,075 total - Purchase
Common Stock
2021-07-06$14.88/sh+450,000$6,696,000→ 3,417,075 total
Footnotes (5)
- [F1]Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering.
- [F2]Represents 225,000 shares of Common Stock acquired by Sands Capital Global Venture Fund II, L.P. ("Sands Venture Fund") and 225,000 shares of Common Stock acquired by ands Capital Life Sciences Pulse Fund ("Sands Pulse Fund") in connection with the closing of the Issuer's initial public offering.
- [F3]Consists of 1,124,719 shares of Common Stock held by Sands Capital Ventures Discovery Fund III, L.P. ("Sands Discovery Fund "). Sands Capital Ventures Discovery Fund III-GP, LLC ("Sands Discovery GP") is the general partner of Sands Discovery Fund. Sands Discovery GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- [F4]Consists of 921,173 shares of Common Stock held by Sands Venture Fund and 921,173 shares of Common Stock held by Sands Pulse Fund. Sands Capital Global Venture Fund II-GP, L.P. ("Sands Venture GP L.P.") is the general partner of Sands Venture Fund and Sands Capital Global Venture Discovery Fund II-GP, LLC ("Sands Venture GP LLC") is the general partner of Sands Venture GP L.P. Sands Venture GP L.P. and Sands Venture GP LLC each disclaims beneficial ownership of such securities except to the extent of its respective pecuniary interest therein.
- [F5]Frank M. Sands holds ultimate voting and investment power over securities held by Sands Discovery Fund, Sands Venture Fund and Sands Pulse Fund. Mr. Sands disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Acumen Pharmaceuticals, Inc.
CIK 0001576885
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001870491
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 5:21 PM ET
- Size
- 19.7 KB